Cost-effectiveness of TAVR in the non-surgical population

References

• Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol 2007;50:2018–9
   PubMed Web of Science ®Google Scholar
• Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58:2130–8
   PubMed Web of Science ®Google Scholar
• Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080–90
   PubMed Web of Science ®Google Scholar
• Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755–63
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597–607
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366:1696–704
   PubMed Web of Science ®Google Scholar
• Hancock-Howard R, Feindel C, Rodes-Cabau J, et al. Transfemoral aortic valve replacement versus medical management in high risk patients with symptomatic aortic valve stenosis: Canadian cost-effectiveness analysis based on the PARTNER trial cohort B findings. J Med Econ (in press)
   Google Scholar
• Neyt M, Van Brabandt H. TAVI: reveal the truth, the whole truth and nothing but the truth. J Med Econ (in press)
   Google Scholar
• Doble B, Blackhouse G, Goeree R, et al. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thorac Cardiovasc Surg 2012; preprint doi:10.1016/j.jtcvs.2012.06.018. (Published online 16 July 2012.)
   Google Scholar
• Gada H, Kapadia SR, Tuzcu EM, et al. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol 2012;109:1326–33
   PubMed Web of Science ®Google Scholar
• Neyt M, Van Brabandt H, Devriese S, et al. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2012;2. doi:10.1136/bmjopen-2012-001032.
   Google Scholar
• Reynolds MR, Magnuson EA, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation 2012;125:1102–9
   PubMed Web of Science ®Google Scholar
• Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2012;98:370–6
   PubMed Web of Science ®Google Scholar
• Hlatky MA, Simons CT. Cost-effectiveness of transcatheter aortic valve replacement. Circulation 2012;125:1076–7
   Google Scholar
• Reynolds MR, Magnuson EA, Lei Y, et al. Health related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 2011;124:1964–72
   PubMed Web of Science ®Google Scholar
• Neyt M, Van Brabandt H. Cost-effectiveness of transcatheter aortic valve replacement: overoptimistic study results and a call for publication of complete trial results. Heart 2012;98:1031–3
   Google Scholar
• Van Brabandt H, Neyt M, Hulstaert F. Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ 2012;345:e4710
   Google Scholar
• U.S. Food and Drug Administration. The Edwards SAPIEN® THV Transcatheter Heart Valve System for patients with severe aortic stenosis who are not candidates for conventional open-heart aortic valve replacement surgery. Briefing document for the Circulatory Systems Device Panel Advisory Committee. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM262935.pdf. Accessed October 25, 2012
   Google Scholar
• Alli OO, Booker JD, Lennon RJ, et al Transcatheter aortic valve implantation: assessing the learning curve. JACC. Cardiovasc Interv 2012;5:72–9
   PubMedGoogle Scholar
• Holmes DR, Jr., Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 2012;59:1200–54
   PubMed Web of Science ®Google Scholar
• Mack MJ, Holmes DR, Jr. Rational dispersion for the introduction of transcatheter valve therapy. JAMA 2011;306:2149–50
   Google Scholar
• Dewey TM. New data from PARTNER continued access (Non-randomized): transapical outcomes after TAVR. Transcatheter Therapeutics 2012;preprint (abstract presentation, October 22, 2012 (Miami, FL))
   Google Scholar
• Kodali S. New data from the PARTNER continued access (Non-randomized): Transfemoral outcomes after TAVR. Transcatheter Therapeutics 2012;preprint (abstract presentation October 22, 2012 (Miami, FL))
   Google Scholar
• Neyt M, Van Brabandt H, Van de Sande S, et al. Transcatheter Aortic Valve Implantation (TAVI): a health technology assessment update. KCE Reports. 2011. p 163. Available at http://www.kce.fgov.be/content/kce-reports. Accessed February 12, 2013
   Google Scholar
• Reynolds MR, Magnuson EA, Lei Y, et al. Cost effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high risk patients with severe aortic stenosis: results from the PARTNER Trial (Cohort A). J Am Coll Cardiol 2012;60:2683--92
   Google Scholar
• Reynolds MR, Magnuson EA, Wang K, et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol 2012;60:548–58
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. http://hcupnet.ahrq.gov/. Accessed August 10, 2012
   Google Scholar